Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2024 Earnings Call Transcript March 7, 2025
Oncolytics Biotech Inc. beats earnings expectations. Reported EPS is $-0.06949, expectations were $-0.08.
Operator: Good morning, and welcome to Oncolytics Biotech Inc.’s fourth quarter and full year 2024 conference call. All participants are in a listen-only mode. There will be a question and answer session at the end of the call. Please be advised that this call is being recorded at the company’s request....
